Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
28.53
+1.06 (3.86%)
At close: Mar 9, 2026, 4:00 PM EDT
27.15
-1.38 (-4.84%)
After-hours: Mar 9, 2026, 5:36 PM EDT
Agios Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -412.78 | 673.73 | -352.09 | -231.8 | 1,605 | |
| Depreciation & Amortization | 5.18 | 5.65 | 6.62 | 8.56 | 9.24 | |
| Loss (Gain) From Sale of Assets | 0.01 | -200.04 | 0.55 | -0.05 | 0.01 | |
| Loss (Gain) From Sale of Investments | -7.31 | -14.65 | -5.08 | -1.2 | 6.95 | |
| Stock-Based Compensation | 52.55 | 42.85 | 44.77 | 49.3 | 53.51 | |
| Other Operating Activities | 22.43 | -877.61 | 28.22 | -117.86 | -1,952 | |
| Change in Accounts Receivable | -6.47 | -1.3 | -0.6 | -2.21 | - | |
| Change in Inventory | -5.3 | -8.54 | -10.58 | -8.49 | - | |
| Change in Accounts Payable | 1.75 | 6.6 | -8.73 | 3.44 | 1.86 | |
| Change in Income Taxes | -0.87 | 0.87 | - | - | - | |
| Change in Other Net Operating Assets | -22.15 | -17.4 | 0.86 | -9.17 | -38.69 | |
| Operating Cash Flow | -372.98 | -389.84 | -296.06 | -309.48 | -407.32 | |
| Capital Expenditures | -4.32 | -1.69 | -1 | -4.88 | -5.74 | |
| Sale of Property, Plant & Equipment | - | 0.04 | 1.33 | 0.96 | - | |
| Divestitures | - | 200 | - | - | - | |
| Sale (Purchase) of Intangibles | -10 | - | -17.5 | - | - | |
| Investment in Securities | 391.5 | -724.05 | 256.75 | 115.39 | -548.42 | |
| Other Investing Activities | - | 889.14 | - | 131.78 | 1,803 | |
| Investing Cash Flow | 377.18 | 363.44 | 239.58 | 243.26 | 1,249 | |
| Long-Term Debt Repaid | - | - | - | -0.33 | -0.58 | |
| Net Debt Issued (Repaid) | - | - | - | -0.33 | -0.58 | |
| Issuance of Common Stock | 8.68 | 14.44 | 5.43 | 2.68 | 37.3 | |
| Repurchase of Common Stock | - | - | - | - | -802.49 | |
| Financing Cash Flow | 8.68 | 14.44 | 5.43 | 2.35 | -765.77 | |
| Net Cash Flow | 12.88 | -11.96 | -51.05 | -63.87 | 75.69 | |
| Free Cash Flow | -377.29 | -391.53 | -297.06 | -314.36 | -413.06 | |
| Free Cash Flow Margin | -698.33% | -1072.73% | -1107.49% | -2207.58% | - | |
| Free Cash Flow Per Share | -6.51 | -6.76 | -5.34 | -5.74 | -6.83 | |
| Cash Income Tax Paid | 0.63 | 43.15 | 1.57 | - | 16.08 | |
| Levered Free Cash Flow | -267.97 | -222.83 | -215.06 | -195.32 | -198.29 | |
| Unlevered Free Cash Flow | -267.97 | -222.83 | -215.06 | -195.32 | -198.29 | |
| Change in Working Capital | -33.04 | -19.77 | -19.06 | -16.43 | -36.82 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.